Dechra Pharmaceuticals
DPH.L
#2481
Rank
โ‚น486.38 B
Marketcap
โ‚น4,270
Share price
0.05%
Change (1 day)
61.66%
Change (1 year)

P/E ratio for Dechra Pharmaceuticals (DPH.L)

P/E ratio at the end of 2022: 68.7

According to Dechra Pharmaceuticals's latest financial reports and stock price the company's current price-to-earnings ratio (TTM) is 7540.05. At the end of 2022 the company had a P/E ratio of 68.7.

P/E ratio history for Dechra Pharmaceuticals from 2001 to 2022

PE ratio at the end of each year

Year P/E ratio Change
202268.7-13.17%
202179.1-13.7%
202091.7-1.36%
201992.927.22%
201873.021.63%
201760.0-23.44%
201678.4115.75%
201536.4341.73%
20148.23-71.96%
201329.314.77%
201225.626.5%
201120.224.58%
201016.2-16.95%
200919.53.92%
200818.842.32%
200713.214.38%
200611.54.99%
200511.03.06%
200410.721.76%
20038.77-27.08%
200212.0-55.77%
200127.2

How to read a P/E ratio?

The Price/Earnings ratio measures the relationship between a company's stock price and its earnings per share. A low but positive P/E ratio stands for a company that is generating high earnings compared to its current valuation and might be undervalued. A company with a high negative (near 0) P/E ratio stands for a company that is generating heavy losses compared to its current valuation.

Companies with a P/E ratio over 30 or a negative one are generaly seen as "growth stocks" meaning that investors typically expect the company to grow or to become profitable in the future.
Companies with a positive P/E ratio bellow 10 are generally seen as "value stocks" meaning that the company is already very profitable and unlikely to strong growth in the future.